Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank93
3Y CAGR+18.2%
5Y CAGR+19.8%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+18.2%/yr
vs +22.7%/yr prior
5Y CAGR
+19.8%/yr
Consistent
Acceleration
-4.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $582.98M | -26.4% |
| 2024 | $792.34M | +70.2% |
| 2023 | $465.63M | +32.0% |
| 2022 | $352.74M | -20.7% |
| 2021 | $444.65M | +88.5% |
| 2020 | $235.84M | +91.8% |
| 2019 | $122.93M | -21.1% |
| 2018 | $155.81M | -50.6% |
| 2017 | $315.62M | -17.7% |
| 2016 | $383.36M | - |